Five things for pharma marketers to know: Thursday, January 14, 2021
Johnson & Johnson to release COVID-19 vaccine trial data; Amgen pays $240 million for autoimmune therapy; Dollar General to pay employees to receive vaccine.
Johnson & Johnson to release COVID-19 vaccine trial data; Amgen pays $240 million for autoimmune therapy; Dollar General to pay employees to receive vaccine.
The Vaccine Project Newsletter for the week of January 11, 2020 is 2,097 words and will take you nine minutes to read.
With Democrats now in control of the Senate, the administration may have opportunities to expand access and affordability.
Plus personnel moves at the Point of Care Communication Council, FCB Health New York and QBFox Healthcomm.
The annual definitive guide to the world of medical marketing agencies will be published in June.
HHS to begin gathering data on hospital vaccinations; Intarcia Therapeutics loses funding from Luxin Venture Capital Group; House Democrats test positive for COVID in riot’s wake.
Haymarket Media’s pharma and healthcare marketing title MM+M joins the party for the initiative’s sixth year celebrating the best in filmmaking on behalf of brands.
Execs from Pfizer, Sanofi and CVS Health shared company updates with the virtual throng.
Sacrificing equity for vaccine expediency is a bad idea, behavioral-science experts warn.
Eli Lilly drug shows promise in slowing cognitive decline; Japan discovers another COVID strain; Valo Health raises $190 million to develop AI platform.
Please login or register first to view this content.